Reaction

Cerebral Aspergillosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 606 reports · 45 co-occurring drugs

As of the last recalculation, Cerebral Aspergillosis appears in 606 FAERS reports alongside 45 co-occurring drug terms. The strongest observed disproportionality signal is VORICONAZOLE INJECTION (PRR 440.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Voriconazole Injection	191	440.7	444.6
Voriconazole	199	334.5	336.8
Amphotericin B	78	245.3	246.8
Micafungin Sodium	40	173.4	174.2
Basiliximab	49	155.6	156.3
Posaconazole Delayed-Release	35	116.1	116.5
Posaconazole	39	88.0	88.3
Obinutuzumab	31	68.2	68.3
Itraconazole	21	63.9	64.1
Ganciclovir Sodium	18	60.2	60.3
Ganciclovir	17	58.7	58.8
Acalabrutinib	19	55.6	55.6
Ibrutinib	107	55.0	55.1
Cefepime	22	54.7	54.7
Fludarabine Phosphate	52	49.6	49.7
Cefepime Hydrochloride	22	48.6	48.7
Tacrolimus Ointment 0.1%	128	44.5	44.5
Tacrolimus Extended-Release Capsules	128	44.4	44.4
Tacrolimus	145	41.5	41.5
Bendamustine Hcl	18	41.1	41.1
Bendamustine Hydrochloride	13	38.1	38.1
Thiotepa	10	36.6	36.6
Mycophenilic Acid	21	36.0	36.1
Crizotinib	12	33.1	33.1
Meropenem	27	30.2	30.2
Piperacillin And Tazobactam	11	30.1	30.1
Moxifloxacin	12	29.8	29.9
Daspone	8	28.6	28.6
Dapsone Gel, 5%	8	28.6	28.6
Terbinafine Hydrochloride	7	27.4	27.4
Busulfan	12	26.7	26.7
Dapsone	8	26.1	26.1
Valganciclovir Hydrochloride Powder,	9	25.7	25.7
Valganciclovir	13	24.2	24.2
Valganciclovir Hydrochloride	13	24.2	24.2
Mycophenolic Acid	21	23.3	23.3
Ceftriaxone	21	22.7	22.7
Pegaspargase	8	22.7	22.7
Anti-Thymocyte Globulin (Rabbit)	5	21.5	21.5
Remdesivir	8	20.9	20.9
Temozolomide	9	14.9	14.9
Doxorubicin	36	14.7	14.7
Polatuzumab Vedotin	4	14.2	14.2
Blinatumomab	4	13.2	13.3
Oseltamivir	3	13.0	13.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.